-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Internet medical treatment is a new type of modern medical treatment method that applies modern computer technology and information technology to the medical process
.
In recent years, Internet medical care has begun to play an increasingly important role in chronic disease management, postoperative patient follow-up management, and helping families of chronic disease patients to achieve online follow-up visits and medicines without leaving home
.
It is worth mentioning that, affected by the epidemic, a number of Internet medical services led by Ali Health have begun to usher in the development of the wind
.
It is understood that in recent years, the revenue and performance of a large number of Internet medical companies have increased significantly, and their stock prices have also skyrocketed.
In particular, the market value of some companies once approached 400 billion Hong Kong dollars
.
However, under the background of the cold online consultation mode and the tightening of supervision on Internet medical care, while the competition of a large number of Internet medical enterprises has become more and more fierce, the stock price and performance have also begun to slow down or even "encountered"
.
It is understood that at the end of October 2021, the National Health and Medical Commission issued the "Regulations on the Supervision of Internet Diagnosis and Treatment (Draft for Comment)", which put forward stricter requirements on the sales model and consultation model of Internet medical platforms, emphasizing that prescriptions should be used before medicines.
, The first consultation offline, it is clearly proposed to prohibit the use of medicines to support doctors
.
At the same time, there are also documents that clearly state that real-name authentication is also required before a doctor receives a consultation to ensure that the doctor receives the doctor himself
.
Under the above background, the stock prices and performance of Internet medical companies represented by Ali Health and JD Health began to be unsatisfactory
.
Among them, Ali Health even reported a loss of 232 million yuan in the middle of 2021
.
However, it is worth noting that the release of regulatory policies can also effectively supervise the chaos in the Internet medical industry and promote the high-quality development of Internet medical enterprises
.
From the perspective of the industry, in 2022, the industry will return to rational growth from explosive growth, and the industry will gradually standardize and develop rapidly
.
In fact, on January 10, the Internet medical stocks of Hong Kong stocks rose collectively, and rebounded significantly for the second consecutive day
.
As of yesterday's close, Alibaba Health and JD Health both rose by more than 10%, Ping An Good Doctor and Yidu Technology rose by about 8%, and ZhongAn Online and Madison Weikang also rose slightly.
.
Today, the Internet medical sector of Hong Kong stocks rose again
.
Among them, as of the noon break, Ping An Good Doctor rose again by 1.
91% after recording an increase of more than 8% in the previous trading day, achieving four consecutive yang
.
In general, despite the fact that the Internet medical industry has been under the background of stricter supervision, the sector as a whole has experienced a large pullback in 2021, and the valuations of many companies have reached historical lows
.
However, under the circumstance that China's medical resources imbalance and medical insurance pressure are still prominent, the industry generally believes that the development prospects of Internet medical care are still very broad, and stricter supervision will be more conducive to improving the industry's entry barriers, which is conducive to leading enterprises to use Higher quality services and products build advantages
.
It just needs to be noted that, in the future, if companies want to share the market, they will need to standardize their operations
.
At present, Internet medical enterprises have reached the point from being encouraged to requiring standardization.
In addition to seizing opportunities, enterprises also need to focus on quality improvement, in order to meet policy and market expectations for the development of Internet medical enterprises and usher in higher revenue.
And performance growth, as well as not being reshuffled by the market, please be out
.
.
In recent years, Internet medical care has begun to play an increasingly important role in chronic disease management, postoperative patient follow-up management, and helping families of chronic disease patients to achieve online follow-up visits and medicines without leaving home
.
It is worth mentioning that, affected by the epidemic, a number of Internet medical services led by Ali Health have begun to usher in the development of the wind
.
It is understood that in recent years, the revenue and performance of a large number of Internet medical companies have increased significantly, and their stock prices have also skyrocketed.
In particular, the market value of some companies once approached 400 billion Hong Kong dollars
.
However, under the background of the cold online consultation mode and the tightening of supervision on Internet medical care, while the competition of a large number of Internet medical enterprises has become more and more fierce, the stock price and performance have also begun to slow down or even "encountered"
.
It is understood that at the end of October 2021, the National Health and Medical Commission issued the "Regulations on the Supervision of Internet Diagnosis and Treatment (Draft for Comment)", which put forward stricter requirements on the sales model and consultation model of Internet medical platforms, emphasizing that prescriptions should be used before medicines.
, The first consultation offline, it is clearly proposed to prohibit the use of medicines to support doctors
.
At the same time, there are also documents that clearly state that real-name authentication is also required before a doctor receives a consultation to ensure that the doctor receives the doctor himself
.
Under the above background, the stock prices and performance of Internet medical companies represented by Ali Health and JD Health began to be unsatisfactory
.
Among them, Ali Health even reported a loss of 232 million yuan in the middle of 2021
.
However, it is worth noting that the release of regulatory policies can also effectively supervise the chaos in the Internet medical industry and promote the high-quality development of Internet medical enterprises
.
From the perspective of the industry, in 2022, the industry will return to rational growth from explosive growth, and the industry will gradually standardize and develop rapidly
.
In fact, on January 10, the Internet medical stocks of Hong Kong stocks rose collectively, and rebounded significantly for the second consecutive day
.
As of yesterday's close, Alibaba Health and JD Health both rose by more than 10%, Ping An Good Doctor and Yidu Technology rose by about 8%, and ZhongAn Online and Madison Weikang also rose slightly.
.
Today, the Internet medical sector of Hong Kong stocks rose again
.
Among them, as of the noon break, Ping An Good Doctor rose again by 1.
91% after recording an increase of more than 8% in the previous trading day, achieving four consecutive yang
.
In general, despite the fact that the Internet medical industry has been under the background of stricter supervision, the sector as a whole has experienced a large pullback in 2021, and the valuations of many companies have reached historical lows
.
However, under the circumstance that China's medical resources imbalance and medical insurance pressure are still prominent, the industry generally believes that the development prospects of Internet medical care are still very broad, and stricter supervision will be more conducive to improving the industry's entry barriers, which is conducive to leading enterprises to use Higher quality services and products build advantages
.
It just needs to be noted that, in the future, if companies want to share the market, they will need to standardize their operations
.
At present, Internet medical enterprises have reached the point from being encouraged to requiring standardization.
In addition to seizing opportunities, enterprises also need to focus on quality improvement, in order to meet policy and market expectations for the development of Internet medical enterprises and usher in higher revenue.
And performance growth, as well as not being reshuffled by the market, please be out
.
